<Disease><Name>HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B</Name><Synonym>APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE</Synonym><OMIM><Number>144010</Number><URL>http://omim.org/entry/144010</URL></OMIM><Orphanet><Number>391665</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=391665</URL></Orphanet><Protein><Number>Apolipoprotein B-100</Number><URL>http://www.uniprot.org/uniprot/P04114</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>2p24.1</Gene><ICD>E78.1</ICD><Summary>rare;autosomal dominant ;Mutations in the apolipoprotein B-100 gene (APOB) can result in a phenotype that is clinically indistinguishable from familial hypercholesterolemia [Austin MA et al. 2004]</Summary><Symptoms><symtomp><id>3368</id><symptom>corneal arcus</symptom><category>EYES</category></symtomp><symtomp><id>2300</id><symptom>coronary heart disease</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2488</id><symptom>myocardial infarction, myocardial ischemia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>4123</id><symptom>xanthelasma</symptom><category>EYES</category></symtomp><symtomp><id>3172</id><symptom>xanthoma</symptom><category>SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>755</id><name>Low-density lipoprotein (LDL)</name><specimen>plasma</specimen><value>increased</value><min>85.00</min><max>135.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1145</id><name>Low-density lipoprotein (LDL)</name><specimen>serum</specimen><value>increased</value><min>90.00</min><max>200.00</max><unit>mg/dl</unit><age>adult</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4619</id><title>Familial defective apolipoprotein B-100: A review</title><author>Andersen LH,</author><journal>J Clin Lipidol</journal><year>2016</year><book /><volume>10</volume><number>6</number><pages>1297-1302</pages><co_aut>et al.</co_aut></literature><literature><id>1818</id><title>LDL-receptor mutations in Europe</title><author>Dedoussis GV</author><journal>Hum Mutat</journal><year>2004</year><book /><volume>24</volume><number>6</number><pages>443-459</pages><co_aut>et al.</co_aut></literature><literature><id>1819</id><title>Familial hypercholesterolemia and coronary heart disease: a HuGE association review</title><author>Austin MA</author><journal>Am J Epidemiol</journal><year>2004</year><book /><volume>160</volume><number>5</number><pages>421-429</pages><co_aut>et al.</co_aut></literature><literature><id>1815</id><title>Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemi</title><author>Gaffney D</author><journal>Atherosclerosis</journal><year>2002</year><book /><volume>162</volume><number>1</number><pages>33-43</pages><co_aut>et al.</co_aut></literature><literature><id>1816</id><title>The molecular mechanism for the genetic disorder familial defective apolipoprotein B100</title><author>Boren J</author><journal>J Biol Chem</journal><year>2001</year><book /><volume>276</volume><number>12</number><pages>9214-9218</pages><co_aut>et al.</co_aut></literature><literature><id>1817</id><title>Familial defective apolipoprotein B-100</title><author>Hansen PS</author><journal>Dan Med Bull</journal><year>1998</year><book /><volume>45</volume><number>4</number><pages>370-382</pages><co_aut /></literature><literature><id>66</id><title>A new type of familial hypercholesterolemia</title><author>Higgins MJP</author><journal>Lancet II</journal><year>1975</year><book /><volume>0</volume><number>0</number><pages>737-740</pages><co_aut>Lecamwasam DS, Galton DJ</co_aut></literature></Literatures></Disease>